Type 2 Diabetes: Epidemiology and Clinical Advances
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Endocrinology & Metabolism".
Deadline for manuscript submissions: 15 June 2024 | Viewed by 127
Special Issue Editor
2. PériTox UMR-I 01, University of Picardie Jules Verne, Chemin du Thil, F-80025 Amiens, France
Interests: diabetes; endocrinology; hyperaldosteronism; paraganglioma; pheochromocytoma; multiple endocrine neoplasia
Special Issue Information
Dear Colleagues,
The global diabetes prevalence in adults was estimated at 10.5% in 2021 and it is predicted to rise to 12.2% in 2045. The prevalence of diabetes and the occurrence of its complications differ by country, race and ethnicity, sex and socioeconomic level. During the last decade, advances in the treatment of type 2 diabetes, the most frequent type of diabetes, have been spectacular. The introduction and widespread use of glucose-lowering drugs with cardiovascular benefits (glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors) are expected to modify the history of diabetes. However, disparities in the prevalence of diabetes or the occurrence of its complications still exist and as the prevention and treatment of cardiovascular complications improve, other complications will come to the fore. This includes diabetic foot ulcers, vascular dementia, periodontitis and some cancers. The main aim of this Special Issue is to provide an update on the changing epidemiology of diabetes and its complications and the impact of the newer glucose-lowering drugs on the natural history of diabetes and its complications. Papers about persistent disparities in the prevalence of diabetes and complications and those about the less studied complications (peripheral artery disease, diabetic foot ulcers, vascular dementia, chronic periodontitis, cancer and infections) are most welcomed.
Dr. Abdallah Al-Salameh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- type 2 diabetes mellitus
- cardiovascular
- diabetic foot ulcers
- vascular dementia
- periodontitis
- cancer
- infections
